Showing results (151-160 of 197) with videos related to
Sort By:
Pageof 20
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2012
Initial analysis of the international association for the study of lung cancer mesothelioma databaseValerie W Rusch, Dorothy Giroux, Catherine Kennedy, et al.Journal of Thoracic Disease|April 26, 2019
Diagnostic and clinical features of lung cancer associated with cystic airspacesAnnemie Snoeckx, Pieter Reyntiens, Laurens Carp, et al.Current Pharmaceutical Biotechnology|May 22, 2014
Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancerChristian Rolfo, Daniele Fanale, David S Hong, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 3, 2019
Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: A population-based studyViki Schillemans, France Vrijens, Cindy De Gendt, et al.Cancer|October 10, 2015
Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its developmentMichael Koller, Sophie Warncke, Marianne J Hjermstad, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committeeHarvey I Pass, Dorothy Giroux, Catherine Kennedy, et al.Clinical Lung Cancer|October 16, 2020
Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating MoodMick van de Wiel, Sofie Derijcke, Daniella Galdermans, et al.European Journal of Cancer (Oxford, England : 1990)|June 25, 2013
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)Mary E R O'Brien, Rabab M Gaafar, Sanjay Popat, et al.Translational Lung Cancer Research|March 26, 2015
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome itChristian Rolfo, Francesco Passiglia, Marta Castiglia, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2016
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International ParticipationHarvey Pass, Dorothy Giroux, Catherine Kennedy, et al.Pageof 20